Loading...
XASX
PGC
Market cap161mUSD
Oct 09, Last price  
0.15AUD
1D
3.57%
1Q
3.57%
Jan 2017
-81.88%
Name

Paragon Care Ltd

Chart & performance

D1W1MN
XASX:PGC chart
P/E
—
P/S
0.07
EPS
—
Div yield, %
—
Shrs. gr., 5y
20.47%
Rev. gr., 5y
73.24%
Revenues
3.68b
+1.84%
371,060100,6231,126,2828,306,59314,661,39115,718,56617,096,44719,416,93132,223,35193,383,052117,192,924117,200,000236,009,000231,689,000235,840,000237,618,000307,630,0002,969,885,0003,613,887,0003,680,544,000
Net income
-16m
L
-1,257,509-1,846,270-355,832147,782851,183-77,484739,6031,084,8912,103,1567,530,52310,174,76110,950,5558,862,000-77,269,0008,279,0006,634,00012,798,0008,381,00020,574,000-16,027,999
CFO
29m
P
-1,000,453-591,329-432,699235,190145,752-310,749725,543-2,085,690809,8747,759,22111,989,3807,559,0001,158,0005,287,00027,463,00019,032,00017,749,00044,452,000-11,348,00029,094,000
Dividend
Sep 18, 20230.006 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems. In addition, the company offers aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; natural, traditional, and complementary health products and services; critical care and dental solutions; urology solutions, such as shockwave therapy, lasers, and accessories for infection control; medical products and consumables; and orthopaedics solutions, including hip and knee arthroplasty, upper and lower extremity, sports medicine, reverse shoulder replacement, and powered surgical tools. Further, it offers medical equipment repair, maintenance, and support services; technology and communication solutions, such as telephony, nurse call, access control, cctv, cordless, and Wi-Fi; supplies medical equipment to veterans, war widows, and families; and veterinary products. Additionally, it is involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. The company is based in Mount Waverley, Australia.

Related entities

Subsidiaries
PARAGON CARE GROUP AUSTRALIA PTY LTD

Key people

Phil Nicholl
Chief Executive Officer · since 2019
Stephen J. Munday
Chief Financial Officer · since 2019
Michael G. Rice
Chief Operations Manager · since 2018
Melanie Leydin
Company Secretary · since 2018
Shane Francis Tanner
Non-Executive Independent Chairman of the Board · since 2005
Bruce Bian
Non-Executive Independent Director · since 2019
Michael Clevin Newton
Non-Executive Independent Director · since 2007
Non-Executive Independent Director · since 2016
IPO date
Oct 15, 1999
Employees
400
Domiciled in
AU
Incorporated in
AU
Headquarters & legal address
77-97 Ricketts Road
MOUNT WAVERLEY, VIC 3149
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT